Kate Whelan

930 total citations · 1 hit paper
9 papers, 485 citations indexed

About

Kate Whelan is a scholar working on Genetics, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kate Whelan has authored 9 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kate Whelan's work include Estrogen and related hormone effects (6 papers), Breast Cancer Treatment Studies (5 papers) and Advanced Breast Cancer Therapies (3 papers). Kate Whelan is often cited by papers focused on Estrogen and related hormone effects (6 papers), Breast Cancer Treatment Studies (5 papers) and Advanced Breast Cancer Therapies (3 papers). Kate Whelan collaborates with scholars based in United States, Canada and Austria. Kate Whelan's co-authors include Kathleen I. Pritchard, Hyman B. Muss, Paul E. Goss, Timothy J. Whelan, Dongsheng Tu, Julie R. Gralow, Wendy R. Parulekar, Kathrin Strasser‐Weippl, James N. Ingle and Nicholas J. Robert and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Queensland's institutional digital repository (The University of Queensland).

In The Last Decade

Kate Whelan

9 papers receiving 473 citations

Hit Papers

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
    2016 411 citations Paul E. Goss, James N. Ingle et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate Whelan United States 5 261 246 188 173 35 9 485
Lindsay Carlsson Canada 9 324 1.2× 215 0.9× 288 1.5× 126 0.7× 73 2.1× 25 667
NR Williams United Kingdom 4 427 1.6× 335 1.4× 431 2.3× 146 0.8× 99 2.8× 10 748
Jan Smeets Netherlands 7 261 1.0× 218 0.9× 282 1.5× 110 0.6× 47 1.3× 8 421
T Palva Finland 8 426 1.6× 179 0.7× 277 1.5× 145 0.8× 61 1.7× 13 663
Aviva G. Asnis-Alibozek United States 5 170 0.7× 117 0.5× 150 0.8× 131 0.8× 68 1.9× 7 489
Nicola Roche United Kingdom 8 315 1.2× 285 1.2× 275 1.5× 68 0.4× 51 1.5× 18 629
Domen Ribnikar Canada 11 291 1.1× 199 0.8× 104 0.6× 151 0.9× 97 2.8× 31 470
Leilani Morales Belgium 6 222 0.9× 68 0.3× 246 1.3× 41 0.2× 30 0.9× 10 388
Christina Yeon United States 8 258 1.0× 70 0.3× 85 0.5× 97 0.6× 76 2.2× 26 367
CM Vachon United States 5 299 1.1× 160 0.7× 94 0.5× 208 1.2× 38 1.1× 9 503

Countries citing papers authored by Kate Whelan

Since Specialization
Citations

This map shows the geographic impact of Kate Whelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Whelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Whelan more than expected).

Fields of papers citing papers by Kate Whelan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Whelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Whelan. The network helps show where Kate Whelan may publish in the future.

Co-authorship network of co-authors of Kate Whelan

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Whelan. A scholar is included among the top collaborators of Kate Whelan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Whelan. Kate Whelan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Almeida, John R. de, Wendy R. Parulekar, Apostolos Christopoulos, et al.. (2023). CCTG HN11: SPECT-CT guided elective contralateral neck treatment (SELECT) for patients with lateralized oropharyngeal cancer—A phase III randomized controlled trial.. Journal of Clinical Oncology. 41(16_suppl). TPS6114–TPS6114. 4 indexed citations
2.
Lemieux, Julie, Michael Brundage, Wendy R. Parulekar, et al.. (2018). Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years. Journal of Clinical Oncology. 36(6). 563–571. 14 indexed citations
3.
Goss, Paul E., James N. Ingle, Kathleen I. Pritchard, et al.. (2016). Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years. New England Journal of Medicine. 375(3). 209–219. 411 indexed citations breakdown →
4.
Goss, Paul E., James N. Ingle, Kathleen I. Pritchard, et al.. (2016). A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.. Journal of Clinical Oncology. 34(18_suppl). LBA1–LBA1. 11 indexed citations
5.
6.
7.
8.
9.
Robertson, Valma J, et al.. (2001). Guidelines for the Clinical Use of Electrophysical Agents. Queensland's institutional digital repository (The University of Queensland). 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lindsay Carlsson Breakdown of academic impact, for papers by NR Williams Breakdown of academic impact, for papers by Jan Smeets Breakdown of academic impact, for papers by T Palva Breakdown of academic impact, for papers by Aviva G. Asnis-Alibozek Breakdown of academic impact, for papers by Nicola Roche Breakdown of academic impact, for papers by Domen Ribnikar Breakdown of academic impact, for papers by Leilani Morales Breakdown of academic impact, for papers by Christina Yeon Breakdown of academic impact, for papers by CM Vachon
Rankless by CCL
2026